# A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CDI-988 in Healthy Adults After Challenge With Snow Mountain Virus

> **NCT07198139** · PHASE1,PHASE2 · RECRUITING · sponsor: **Cocrystal Pharma, Inc.** · enrollment: 40 (estimated)

## Conditions studied

- Norovirus

## Interventions

- **DRUG:** CDI-988
- **DRUG:** Placebo
- **OTHER:** Snow Mountain Virus

## Key facts

- **NCT ID:** NCT07198139
- **Lead sponsor:** Cocrystal Pharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2026-10-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07198139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07198139, "A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CDI-988 in Healthy Adults After Challenge With Snow Mountain Virus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07198139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*